# Clinical Study on the Treatment of Type 1 Diabetes With CNK-UT009 Cell Injection

> **NCT07051564** · NA · RECRUITING · sponsor: **Zibo Central Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Type 1 Diabetes (T1D)

## Interventions

- **BIOLOGICAL:** CNK-UT009 cell injection

## Key facts

- **NCT ID:** NCT07051564
- **Lead sponsor:** Zibo Central Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-06
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07051564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07051564, "Clinical Study on the Treatment of Type 1 Diabetes With CNK-UT009 Cell Injection". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07051564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
